Wakamoto Pharmaceutical
4512.T
#10163
Rank
โ‚ฌ56.95 M
Marketcap
1,64ย โ‚ฌ
Share price
0.70%
Change (1 day)
5.07%
Change (1 year)

Revenue for Wakamoto Pharmaceutical (4512.T)

Revenue in 2026 (TTM): โ‚ฌ55.86 Million

According to Wakamoto Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚ฌ58.86 Million. In 2025 the company made a revenue of โ‚ฌ54.97 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ73.34 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Wakamoto Pharmaceutical from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ55.86 M1.63%
2025 โ‚ฌ54.97 M-25.04%
2024 โ‚ฌ73.34 M43.39%
2023 โ‚ฌ51.14 M-13.26%
2022 โ‚ฌ58.96 M-11.76%
2021 โ‚ฌ66.82 M-4.37%
2020 โ‚ฌ69.87 M-23.39%
2019 โ‚ฌ91.21 M8.51%
2018 โ‚ฌ84.05 M4.03%
2017 โ‚ฌ80.8 M-16.15%
2016 โ‚ฌ96.35 M13.9%
2015 โ‚ฌ84.59 M5.26%
2014 โ‚ฌ80.37 M5.77%
2013 โ‚ฌ75.98 M-14%
2012 โ‚ฌ88.36 M-5.88%
2011 โ‚ฌ93.88 M13.6%
2010 โ‚ฌ82.64 M13.37%
2009 โ‚ฌ72.9 M